US Stock MarketDetailed Quotes
ACXP Acurx Pharmaceuticals
- 1.860
- -0.020-1.06%
Close Nov 1 16:00 ET
- 1.860
- 0.0000.00%
Post 20:02 ET
30.22MMarket Cap-1603P/E (TTM)
1.910High1.825Low22.01KVolume1.910Open1.880Pre Close40.53KTurnover0.16%Turnover RatioLossP/E (Static)16.25MShares5.28052wk High8.82P/B25.74MFloat Cap1.52052wk Low--Dividend TTM13.84MShs Float8.820Historical High--Div YieldTTM4.52%Amplitude1.170Historical Low1.841Avg Price1Lot Size
Acurx Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 19.64%4.12M | 50.81%4.38M | 20.55%14.58M | 56.86%5.11M | -12.05%3.11M | 31.47%3.45M | 8.72%2.9M | -5.63%12.09M | 24.11%3.26M | -23.71%3.54M |
| Selling and administrative expenses | 34.37%2.3M | 49.57%2.82M | 16.29%8.53M | 73.53%3.17M | -9.46%1.77M | 0.00%1.71M | 1.95%1.89M | -31.95%7.34M | -4.34%1.83M | -44.51%1.95M |
| -General and administrative expense | 34.37%2.3M | 49.57%2.82M | 16.29%8.53M | 73.53%3.17M | -9.46%1.77M | 0.00%1.71M | 1.95%1.89M | -31.95%7.34M | -4.34%1.83M | -44.51%1.95M |
| Research and development costs | 5.14%1.83M | 53.12%1.56M | 27.12%6.04M | 35.60%1.94M | -15.21%1.35M | 90.46%1.74M | 24.02%1.02M | 134.18%4.75M | 100.03%1.43M | 41.18%1.59M |
| Operating profit | -19.64%-4.12M | -50.81%-4.38M | -20.55%-14.58M | -56.86%-5.11M | 12.05%-3.11M | -31.47%-3.45M | -8.72%-2.9M | 5.63%-12.09M | -24.11%-3.26M | 23.71%-3.54M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | ||||||||||
| Income before tax | -19.64%-4.12M | -50.81%-4.38M | -20.55%-14.58M | -56.86%-5.11M | 12.05%-3.11M | -31.47%-3.45M | -8.72%-2.9M | 5.14%-12.09M | -24.11%-3.26M | 23.71%-3.54M |
| Income tax | ||||||||||
| Net income | -19.64%-4.12M | -50.81%-4.38M | -20.55%-14.58M | -56.86%-5.11M | 12.05%-3.11M | -31.47%-3.45M | -8.72%-2.9M | 5.14%-12.09M | -24.11%-3.26M | 23.71%-3.54M |
| Net income continuous Operations | -19.64%-4.12M | -50.81%-4.38M | -20.55%-14.58M | -56.86%-5.11M | 12.05%-3.11M | -31.47%-3.45M | -8.72%-2.9M | 5.14%-12.09M | -24.11%-3.26M | 23.71%-3.54M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -19.64%-4.12M | -50.81%-4.38M | -20.55%-14.58M | -56.86%-5.11M | 12.05%-3.11M | -31.47%-3.45M | -8.72%-2.9M | 5.14%-12.09M | -24.11%-3.26M | 23.71%-3.54M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -19.64%-4.12M | -50.81%-4.38M | -20.55%-14.58M | -56.86%-5.11M | 12.05%-3.11M | -31.47%-3.45M | -8.72%-2.9M | 5.14%-12.09M | -24.11%-3.26M | 23.71%-3.54M |
| Basic earnings per share | 7.14%-0.26 | -12.00%-0.28 | -2.68%-1.15 | -35.71%-0.38 | 25.00%-0.24 | -7.69%-0.28 | 3.85%-0.25 | 24.83%-1.12 | -27.27%-0.28 | 30.43%-0.32 |
| Diluted earnings per share | 7.14%-0.26 | -12.00%-0.28 | -2.68%-1.15 | -35.71%-0.38 | 25.00%-0.24 | -7.69%-0.28 | 3.85%-0.25 | 24.83%-1.12 | -27.27%-0.28 | 30.43%-0.32 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data